Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00249535 · ClinicalTrials.gov registry record · NA

Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2

A NA study of Cocaine Dependence, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT00249535 is a NA study of Cocaine Dependence that has completed, run by UConn Health. The registered enrollment target is 240 participants, below the 292-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00249535, a NA study of Cocaine Dependence, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare voucher-based contingency management (CM) procedures to a lower-cost CM system that provides opportunities to win prizes. Cocaine-dependent outpatients are randomly assigned to (a) standard treatment, (b) standard treatment plus usual magnitude prize CM, (c) standard treatment plus higher magnitude prize CM, or (d) standard treatment plus voucher CM. Urine and breath samples are collected 2-3x/week for 14 weeks. Follow-up interviews are conducted at 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.

Conditions Studied

Interventions

  • BEHAVIORAL Contingency management

Study Locations (1)

Connecticut

  • UConn Health Center - Farmington

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2005-03
Est. Completion 2011-07
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT00249535

The ClinicalTrials.gov registry entry for NCT00249535 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (18% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Contingency management is the first listed.

NCT00249535 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00249535 about?

NCT00249535 is a clinical study titled "Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2". The purpose of this study is to compare voucher-based contingency management (CM) procedures to a lower-cost CM system that provides opportunities to win prizes. Cocaine-dependent outpatients are randomly assigned to (a) standard treatment, (b) standard treatment plus usual magnitude prize CM, (c) s...

What is the current status of trial NCT00249535?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2005-03. Estimated completion is 2011-07.

What conditions does trial NCT00249535 study?

This clinical trial studies the following conditions: Cocaine Dependence.

What interventions are being tested in trial NCT00249535?

The interventions under investigation include: Contingency management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00249535?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00249535 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cocaine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.